European Market Open: Virus disruption weighs on markets
Joshua Warner December 22, 2020 2:56 PM
The disruption being caused by a new strain of the coronavirus is expected to continue to weigh on markets this morning.
- European markets are set to open markedly lower this morning as a new strain of the coronavirus continues to cause chaos in Europe.
- With just 10 days left to strike a Brexit deal, reports this morning suggest the UK and the EU are edging closer toward an agreement but that no-deal remains a likely possibility.
- In forex, both sterling and the euro have slipped further against the dollar.
- In commodities, oil prices slipped back below $50 as virus fears weaken the outlook for oil demand.
FTSE 100 to head lower
The FTSE 100 is set to open 0.7% lower this morning at 6376.3 after ending the trading session yesterday at 6423.8.
European indices to follow
The Euro STOXX Index is called to open at 3455.5, down 0.7% after closing at 3481.6 on Monday.
Germany’s DAX is set to open 0.8% lower at 13261.5 from 13369.8.
Meanwhile, France’s CAC 40 is also set to open 0.8% lower at 5400.6 from 5444.8 at the end of play yesterday.
The new virus strain identified in the UK has continued to prompt other nations to impose travel restrictions on the country. More than 40 countries are now thought to have banned UK arrivals, while the border with France also remains closed to hauliers.
European leaders are discussing a co-ordinated approach to the new variant of the virus, while France is looking at how the border could be reopened using new health protocols. It comes as the UK’s chief scientific advisor Patrick Vallance warned it is likely that more areas of the country will need to be put under tougher tier 4 restrictions after Christmas to try and keep on top of the new strain, which health secretary Matt Hancock has described as ‘out of control’.
EU approves first vaccine
The European Medicines Agency (EMA) has approved the Pfizer-BioNTech vaccine, paving the way for EU member states to begin vaccinating their 450 million-strong population as early as Sunday. Germany and Spain are among those that have said they will start rolling it out as soon as possible.
The EMA is expected to review another vaccine developed by US outfit Moderna in early January which, if approved, would give the bloc two vaccines to distribute. Although the approval is key in the fight against the virus, it is becoming increasingly clear that it will not end the pandemic quickly and that tough restrictions will likely be needed well into 2021.
10 days to strike a Brexit deal
The Brexit clock continues to tick down, with UK prime minister Boris Johnson warning yesterday that the ‘position is unchanged’ and that problems remain. He also reiterated that a no-deal Brexit would be ‘entirely satisfactory’.
However, reports this morning suggest the two sides could be edging toward a compromise on tough sticking points that are preventing a deal. Bloomberg reported that the UK is now insisting on cutting the value of fish the EU can catch in UK waters by one-third, compared to a 60% cut proposed last week. The EU is thought to be standing firm at a 25% reduction, but that has also moved from an initial 18%.
This suggests both sides are still desperately trying to strike a last-minute trade deal, but the tight timeframe raises questions about whether any deal would be ratified in time before December 31.
Commodities: Oil slips back below $50
Brent trades at $49.74 a barrel this morning, nudging down after ending yesterday at $50.82, while WTI followed lower to $46.79 from $47.86.
Market-moving events in the economic calendar
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.